Seminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.

The Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.

The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.

ACTA OPHTHALMOLOGICA, published by Wiley, is a premier academic journal dedicated to advancing the field of ophthalmology and related medical disciplines. Established in 1923 and maintaining esteemed status through converged years until 1994, and then from 2008 to the present, this journal has consistently delivered pioneering research, reviews, and clinical advancements essential for both practitioners and researchers in eye care. With an impressive impact factor and ranking within the top 15 of its category, ACTA OPHTHALMOLOGICA stands as a Q1 journal in both Medicine (Miscellaneous) and Ophthalmology, reflecting its significant contribution to the field. Although it is not an open-access journal, it continues to offer valuable insights and empirical findings that inform clinical practices and innovative research approaches. As such, it remains a vital resource for scholars, clinicians, and students keen to stay at the forefront of ophthalmological science.

Journal of the Egyptian Ophthalmological Society is a premier academic journal dedicated to advancing the field of ophthalmology through high-quality peer-reviewed research. Published by Wolters Kluwer Medknow Publications, this journal plays a critical role in disseminating vital findings and innovations in eye care, fostering knowledge exchange among researchers, practitioners, and educators worldwide. Since its transformation to Open Access in 2014, it has significantly enhanced the accessibility of eye health information, thereby broadening its impact on the global scientific community. With an ISSN of 2090-0686 and an E-ISSN of 2314-6648, the journal aims to tackle contemporary issues in ophthalmology, including clinical practices, public health, and technological advancements in eye care. The journal's commitment to excellence ensures that it remains a vital resource for those looking to contribute meaningfully to this dynamic and crucial field.

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.